219 related articles for article (PubMed ID: 28243796)
1. Monoclonal gammopathy of undetermined significance and bone health outcomes: a systematic review and exploratory meta-analysis.
Veronese N; Luchini C; Solmi M; Sergi G; Manzato E; Stubbs B
J Bone Miner Metab; 2018 Jan; 36(1):128-132. PubMed ID: 28243796
[TBL] [Abstract][Full Text] [Related]
2. Disrupted radial and tibial microarchitecture in patients with monoclonal gammopathy of undetermined significance.
Stein EM; Dash A; Bucovsky M; Agarwal S; Fu J; Lentzsch S; Shane E
Osteoporos Int; 2019 Mar; 30(3):629-635. PubMed ID: 30488275
[TBL] [Abstract][Full Text] [Related]
3. Bone tissue quality in patients with monoclonal gammopathy of uncertain significance.
Orduna G; Mellibovsky L; Abella E; Nogués X; Granero R; García-Giralt N; Pineda-Moncusí M; Güerri-Fernández R; Prieto-Alhambra D; Díez-Pérez A
J Bone Miner Metab; 2020 Jul; 38(4):563-569. PubMed ID: 31974675
[TBL] [Abstract][Full Text] [Related]
4. Lumbar bone mineral density as the major factor determining increased prevalence of vertebral fractures in monoclonal gammopathy of undetermined significance.
Pepe J; Petrucci MT; Nofroni I; Fassino V; Diacinti D; Romagnoli E; Minisola S
Br J Haematol; 2006 Sep; 134(5):485-90. PubMed ID: 16848794
[TBL] [Abstract][Full Text] [Related]
5. Use of trabecular bone score for risk stratification of patients with monoclonal gammopathy of undetermined significance.
Sfeir JG; Pena Guzman TD; Bedatsova L; Broski SM; Drake MT
Bone; 2020 Aug; 137():115394. PubMed ID: 32360588
[TBL] [Abstract][Full Text] [Related]
6. Untangling fracture risk in monoclonal gammopathy of undetermined significance: A population-based cohort study.
Rögnvaldsson S; Aspelund T; Thorsteinsdóttir S; Turesson I; Björkholm M; Landgren O; Kristinsson SY
Eur J Haematol; 2021 Jul; 107(1):137-144. PubMed ID: 33840154
[TBL] [Abstract][Full Text] [Related]
7. Vitamin K antagonists' use and fracture risk: results from a systematic review and meta-analysis.
Veronese N; Bano G; Bertozzo G; Granziera S; Solmi M; Manzato E; Sergi G; Cohen AT; Correll CU
J Thromb Haemost; 2015 Sep; 13(9):1665-75. PubMed ID: 26179400
[TBL] [Abstract][Full Text] [Related]
8. Nephrolithiasis, bone mineral density, osteoporosis, and fractures: a systematic review and comparative meta-analysis.
Lucato P; Trevisan C; Stubbs B; Zanforlini BM; Solmi M; Luchini C; Girotti G; Pizzato S; Manzato E; Sergi G; Giannini S; Fusaro M; Veronese N
Osteoporos Int; 2016 Nov; 27(11):3155-3164. PubMed ID: 27289533
[TBL] [Abstract][Full Text] [Related]
9. Bone disease in monoclonal gammopathy of undetermined significance: results from a screened population-based study.
Thorsteinsdottir S; Lund SH; Lindqvist EK; Thordardottir M; Sigurdsson G; Costello R; Burton D; Steingrimsdottir H; Gudnason V; Eiriksdottir G; Siggeirsdottir K; Harris TB; Landgren O; Kristinsson SY
Blood Adv; 2017 Dec; 1(27):2790-2798. PubMed ID: 29296931
[TBL] [Abstract][Full Text] [Related]
10. Bone mineral density, osteoporosis, and fractures among people with eating disorders: a systematic review and meta-analysis.
Solmi M; Veronese N; Correll CU; Favaro A; Santonastaso P; Caregaro L; Vancampfort D; Luchini C; De Hert M; Stubbs B
Acta Psychiatr Scand; 2016 May; 133(5):341-51. PubMed ID: 26763350
[TBL] [Abstract][Full Text] [Related]
11. Altered cortical microarchitecture in patients with monoclonal gammopathy of undetermined significance.
Farr JN; Zhang W; Kumar SK; Jacques RM; Ng AC; McCready LK; Rajkumar SV; Drake MT
Blood; 2014 Jan; 123(5):647-9. PubMed ID: 24227822
[TBL] [Abstract][Full Text] [Related]
12. Fracture risk in monoclonal gammopathy of undetermined significance.
Melton LJ; Rajkumar SV; Khosla S; Achenbach SJ; Oberg AL; Kyle RA
J Bone Miner Res; 2004 Jan; 19(1):25-30. PubMed ID: 14753733
[TBL] [Abstract][Full Text] [Related]
13. Monoclonal gammopathy of undetermined significance and risk of skeletal fractures: a population-based study.
Kristinsson SY; Tang M; Pfeiffer RM; Björkholm M; Blimark C; Mellqvist UH; Wahlin A; Turesson I; Landgren O
Blood; 2010 Oct; 116(15):2651-5. PubMed ID: 20610813
[TBL] [Abstract][Full Text] [Related]
14. Fracture risk in patients with monoclonal gammopathy of undetermined significance.
Gregersen H; Jensen P; Gislum M; Jørgensen B; Sørensen HT; Nørgaard M
Br J Haematol; 2006 Oct; 135(1):62-7. PubMed ID: 16925792
[TBL] [Abstract][Full Text] [Related]
15. Monoclonal gammopathy of undetermined significance, multiple myeloma, and osteoporosis.
Bouvard B; Royer M; Chappard D; Audran M; Hoppé E; Legrand E
Joint Bone Spine; 2010 Mar; 77(2):120-4. PubMed ID: 20097594
[TBL] [Abstract][Full Text] [Related]
16. Fracture incidence and association with bone mineral density in elderly men and women: the Rotterdam Study.
Schuit SC; van der Klift M; Weel AE; de Laet CE; Burger H; Seeman E; Hofman A; Uitterlinden AG; van Leeuwen JP; Pols HA
Bone; 2004 Jan; 34(1):195-202. PubMed ID: 14751578
[TBL] [Abstract][Full Text] [Related]
17. Monoclonal Gammopathy of Undetermined Significance (MGUS)Monoclonal Gammopathy of Undetermined Significance (MGUS).
Viera S; Ludek P; Zdeněk A; Marta K; Martin Š; Sabina Š; Zdeněk K
Klin Onkol; 2018; 31(4):270-276. PubMed ID: 30541309
[TBL] [Abstract][Full Text] [Related]
18. Monoclonal Gammopathies in a Fracture Liaison Service.
McCall B; Ibrahim Z; Barth P; Aaron RK
R I Med J (2013); 2022 Oct; 105(8):28-32. PubMed ID: 36173906
[TBL] [Abstract][Full Text] [Related]
19. Hyperuricemia protects against low bone mineral density, osteoporosis and fractures: a systematic review and meta-analysis.
Veronese N; Carraro S; Bano G; Trevisan C; Solmi M; Luchini C; Manzato E; Caccialanza R; Sergi G; Nicetto D; Cereda E
Eur J Clin Invest; 2016 Nov; 46(11):920-930. PubMed ID: 27636234
[TBL] [Abstract][Full Text] [Related]
20. What is the significance of monoclonal gammopathy of undetermined significance?
Atkin C; Richter A; Sapey E
Clin Med (Lond); 2018 Oct; 18(5):391-396. PubMed ID: 30287433
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
